Relay Therapeutics to Announce First Quarter 2025 Financial Results and Corporate Highlights on May 5, 2025

Core Insights - Relay Therapeutics is a clinical-stage precision medicine company focused on transforming the drug discovery process through advanced computational and experimental technologies [2] Financial Results Announcement - Relay Therapeutics will report its first quarter 2025 financial results and corporate highlights on May 5, 2025, after U.S. financial markets close [1] Company Overview - The company utilizes its Dynamo® platform, which integrates various computational and experimental approaches to target previously challenging protein targets in drug discovery [2] - Relay Therapeutics aims to enhance small molecule therapeutic discovery specifically in targeted oncology and genetic disease indications [2]